NVST
Envista Holdings CorpNYSEHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
90.29
PEG
0.87
P/B
1.37
P/S
1.56
EV/EBITDA
13.39
DCF Value
$47.86
FCF Yield
5.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.0%
Operating Margin
8.5%
Net Margin
1.7%
ROE
1.5%
ROA
0.8%
ROIC
1.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $750.6M | $32.9M | $0.20 |
| FY 2025 | $2.72B | $47.0M | $0.28 |
| Q3 2025 | $669.9M | $-30.3M | $-0.18 |
| Q2 2025 | $682.1M | $26.4M | $0.16 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
0.98
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.